相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modulating Antiangiogenic Resistance by Inhibiting the Signal Transducer and Activator of Transcription 3 Pathway in Glioblastoma
John de Groot et al.
Oncotarget (2015)
Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3
Xiangrong Cui et al.
CANCER SCIENCE (2014)
Mathematical Modeling of PDGF-Driven Glioblastoma Reveals Optimized Radiation Dosing Schedules
Kevin Leder et al.
CELL (2014)
Immunotherapy for Brain Cancer: Recent Progress and Future Promise
Christopher M. Jackson et al.
CLINICAL CANCER RESEARCH (2014)
PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression
Carrie R. Muh et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas
Shuai Wang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IB both in vitro and in vivo
Guang Yang et al.
NEURO-ONCOLOGY (2014)
JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma
Qifan Zheng et al.
NEURO-ONCOLOGY (2014)
STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma
Guo-Shi Lin et al.
MEDICAL ONCOLOGY (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
In vivo radiation response of proneural glioma characterized by protective p53 transcriptional program and proneural-mesenchymal shift
John Halliday et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis
Berenice Ortiz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes
Michael Xiang et al.
SCIENCE SIGNALING (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
EGFR Phosphorylates Tumor-Derived EGFRvIll Driving STAT3/5 and Progression in Glioblastoma
Qi-Wen Fan et al.
CANCER CELL (2013)
Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
Eunhee Kim et al.
CANCER CELL (2013)
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Krishna P. L. Bhat et al.
CANCER CELL (2013)
A DNA Methylation Prognostic Signature of Glioblastoma: Identification of NPTX2-PTEN-NF-κB Nexus
Sudhanshu Shukla et al.
CANCER RESEARCH (2013)
A Novel EGFR Isoform Confers Increased Invasiveness to Cancer Cells
Min Zhou et al.
CANCER RESEARCH (2013)
miR-124 Inhibits STAT3 Signaling to Enhance T Cell-Mediated Immune Clearance of Glioma
Jun Wei et al.
CANCER RESEARCH (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops
Libing Song et al.
CELL RESEARCH (2013)
Targeting Protein Kinase CK2 Suppresses Prosurvival Signaling Pathways and Growth of Glioblastoma
Ying Zheng et al.
CLINICAL CANCER RESEARCH (2013)
Proteome-wide discovery of mislocated proteins in cancer
KiYoung Lee et al.
GENOME RESEARCH (2013)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres
Monica Patane et al.
MOLECULAR CANCER (2013)
The integrated landscape of driver genomic alterations in glioblastoma
Veronique Frattini et al.
NATURE GENETICS (2013)
MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-κB activity
Hongping Xia et al.
NEURO-ONCOLOGY (2013)
Essential role of cooperative NF-κB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma
D. Kesanakurti et al.
ONCOGENE (2013)
NF-κB-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in Glioblastoma
Braden C. McFarland et al.
PLOS ONE (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Opposing Effect of EGFRWT on EGFRvIII-Mediated NF-κB Activation with RIP1 as a Cell Death Switch
Vineshkumar Thidil Puliyappadamba et al.
CELL REPORTS (2013)
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
Yihui Fan et al.
PROTEIN & CELL (2013)
Regulation of HGF Expression by Delta EGFR-Mediated c-Met Activation in Glioblastoma Cells
Jeannine Garnett et al.
NEOPLASIA (2013)
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
Kan V. Lu et al.
CANCER CELL (2012)
Endothelial Expression of TNF Receptor-1 Generates a Proapoptotic Signal Inhibited by Integrin α6β1 in Glioblastoma
Ping Huang et al.
CANCER RESEARCH (2012)
Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity
Youngmi Kim et al.
GENES & DEVELOPMENT (2012)
MicroRNA-30e*promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop
Lili Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets
Libing Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights
Kimberly Ng et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression
Shinji Kohsaka et al.
MOLECULAR CANCER THERAPEUTICS (2012)
IL6-Mediated Suppression of miR-200c Directs Constitutive Activation of Inflammatory Signaling Circuit Driving Transformation and Tumorigenesis
Matjaz Rokavec et al.
MOLECULAR CELL (2012)
EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis
Weiwei Yang et al.
MOLECULAR CELL (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma
Tsuyoshi Fukushima et al.
NEURO-ONCOLOGY (2012)
Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma
Tiffany A. Doucette et al.
NEURO-ONCOLOGY (2012)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
Therese A. Dolecek et al.
NEURO-ONCOLOGY (2012)
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
R. Bonavia et al.
ONCOGENE (2012)
Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network
Kristen M. Holmes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
Sergei I. Grivennikov et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy
Isabelle Coupienne et al.
BIOCHEMICAL PHARMACOLOGY (2011)
A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway
Ying Zheng et al.
BLOOD (2011)
A Developmental Taxonomy of Glioblastoma Defined and Maintained by MicroRNAs
Tae-Min Kim et al.
CANCER RESEARCH (2011)
MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients
Radek Lakomy et al.
CANCER SCIENCE (2011)
An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma
Pavel Sumazin et al.
CELL (2011)
Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma
Braden C. McFarland et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The neurobiology of gliomas: from cell biology to the development of therapeutic approaches
Manfred Westphal et al.
NATURE REVIEWS NEUROSCIENCE (2011)
NFKBIA Deletion in Glioblastomas.
Markus Bredel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Blockade of the NFκB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo
L. Nogueira et al.
ONCOGENE (2011)
A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma
Sujaya Srinivasan et al.
PLOS ONE (2011)
Hypoxia Potentiates Glioma-Mediated Immunosuppression
Jun Wei et al.
PLOS ONE (2011)
The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells
Sarah Ball et al.
PLOS ONE (2011)
Oncogenic EGFR Signaling Activates an mTORC2-NF-κB Pathway That Promotes Chemotherapy Resistance
Kazuhiro Tanaka et al.
CANCER DISCOVERY (2011)
The NFκB pathway: a therapeutic target in glioblastoma
Lorena Nogueira et al.
ONCOTARGET (2011)
The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas
Christian Senft et al.
BMC CANCER (2010)
Minimally perturbing a gene regulatory network to avoid a disease phenotype: the glioma network as a test case
Guy Karlebach et al.
BMC SYSTEMS BIOLOGY (2010)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Dietary Curcumin Attenuates Glioma Growth in a Syngeneic Mouse Model by Inhibition of the JAK1,2/STAT3 Signaling Pathway
Jakob Weissenberger et al.
CLINICAL CANCER RESEARCH (2010)
Intratumoral Mediated Immunosuppression is Prognostic in Genetically Engineered Murine Models of Glioma and Correlates to Immunotherapeutic Responses
Ling-Yuan Kong et al.
CLINICAL CANCER RESEARCH (2010)
NF-κB and STAT3 signaling in glioma: targets for future therapies
George P. Atkinson et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
Surasak Phuphanich et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Quantitative Phosphoproteomic Analysis of the STAT3/IL-6/HIF1 alpha Signaling Network: An Initial Study in GSC11 Glioblastoma Stem Cells
Carol L. Nilsson et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway
Jun Wei et al.
MOLECULAR CANCER THERAPEUTICS (2010)
STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
Dimitrios Iliopoulos et al.
MOLECULAR CELL (2010)
The transcriptional network for mesenchymal transformation of brain tumours
Maria Stella Carro et al.
NATURE (2010)
Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology
Kimberly R. Porter et al.
NEURO-ONCOLOGY (2010)
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Adam Wu et al.
NEURO-ONCOLOGY (2010)
Protein kinase Cε mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2)
M. H. Aziz et al.
ONCOGENE (2010)
Targeting A20 Decreases Glioma Stem Cell Survival and Tumor Growth
Anita B. Hjelmeland et al.
PLOS BIOLOGY (2010)
MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme
Yiming Li et al.
BRAIN RESEARCH (2009)
Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
Heehyoung Lee et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Dimitrios Iliopoulos et al.
CELL (2009)
CK2 and its role in Wnt and NF-κB signaling: Linking development and cancer
I. Dominguez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
The prolyl isomerase Pin1 regulates the NF-κB signaling pathway and interleukin-8 expression in glioblastoma
G. P. Atkinson et al.
ONCOGENE (2009)
The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers
Selvaraju Veeriah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth
Hui Wang et al.
STEM CELLS (2009)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
Yang Chen et al.
CANCER LETTERS (2008)
MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells
Thales Papagiannakopoulos et al.
CANCER RESEARCH (2008)
Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: Implications for STAT-3 activation and gene expression
Emily C. Brantley et al.
CLINICAL CANCER RESEARCH (2008)
The ING4 Tumor Suppressor Attenuates NF-κB Activity at the Promoters of Target Genes
Susan Nozell et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Signal transducer and activator of transcription-3: A molecular hub for signaling pathways in gliomas
Emily C. Brantley et al.
MOLECULAR CANCER RESEARCH (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Epidemiology of brain tumors
James L. Fisher et al.
NEUROLOGIC CLINICS (2007)
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients
S. Farzana Hussain et al.
CANCER RESEARCH (2007)
A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo
A. Iwamaru et al.
ONCOGENE (2007)
Radiotherapy for glioblastoma in the elderly
Florence Keime-Guibert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
D. S. Basseres et al.
ONCOGENE (2006)
Mechanisms of angiogenesis in gliomas
O. Kargiotis et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
NF-κB and cancer:: Mechanisms and targets
Michael Karin
MOLECULAR CARCINOGENESIS (2006)
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
W Stummer et al.
LANCET ONCOLOGY (2006)
Circuitry of nuclear factor κB signaling
A Hoffmann et al.
IMMUNOLOGICAL REVIEWS (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Extensive modulation of a set of microRNAs in primary glioblastoma
SA Ciafrè et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)
D Yin et al.
ONCOGENE (2005)
The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-κB)
E Jüttler et al.
NEUROPHARMACOLOGY (2004)
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial
W Roa et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas
M Glantz et al.
CANCER (2003)
2-Methoxyestradiol interferes with NFκB transcriptional activity in primitive neuroectodermal brain tumors:: implications for management
AP Kumar et al.
CARCINOGENESIS (2003)
Expression of nuclear factor-κB, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas
S Hayashi et al.
NEUROLOGIA MEDICO-CHIRURGICA (2001)
Serine phosphorylation of STATs
T Decker et al.
ONCOGENE (2000)
分享论文
